About two years ago, New Jersey company Johnson & Johnson made the widely-publicized decision to recall the ASR artificial hip manufactured and sold by DePuy Orthopaedics, a unit of J&J. The company set aside $3 billion to compensate people who had filed personal injury lawsuits in connection with the defective products, and seemed to acknowledge the danger of metal-on-metal artificial hips.
According to a 2011 report from the U.S. Food and Drug Administration (FDA), the number of "adverse event" reports for medical devices has increased by about 15 percent every year for the last 10 years. If you are a regular reader of our New Jersey personal injury blog, you are likely not surprised by this increase.
In recent weeks, we have written extensively on the issues surrounding the DePuy Orthopaedics articular surface replacement (ASR) metal-on-metal hip replacement joints. Essentially, these faulty medical products have caused thousands of people in New Jersey and throughout the country to suffer debilitating pain and lasting injury as a result of friction in the joint's metal components.
Earlier this week, we wrote about the recent influx of product liability lawsuits against New Jersey-based Johnson & Johnson regarding its vaginal mesh implant products, which have resulted in injury and death in hundreds of women throughout the country. The vaginal mesh suits are not the only litigation facing Johnson & Johnson at this time. The company is also defending itself against a growing class action products liability lawsuit after "mechanical failure" forced the recall of hundreds of artificial joints.
Earlier this week, we wrote about Johnson & Johnson unit DePuy Orthopaedics and the contention that its A.S.R. hip replacement implant is a defective product. When the A.S.R. was introduced, it was promoted as a major breakthrough, and as an implant that would last much longer than similar products. When the allegations were first brought against DePuy, the company maintained its self-promotion, claiming that surgical mistake was behind patients' pain and injury, not the product itself. Recently, however, DePuy announced that it is phasing out the A.S.R. device, but not for safety reasons. Instead, the company claims that lagging sales are behind the recall.
Over the last year, health care product manufacturer Johnson & Johnson has come under scrutiny after multiple allegations of injuries caused by various products. On this blog alone, we have written about the harm reportedly caused by the birth control patch and children's over-the-counter cold medicines, both of which have given rise to products liability litigation. Recently, a new controversy has risen after claims that an artificial replacement hip manufactured by DePuy Orthopaedics, a unit of Johnson & Johnson, was not only failing, but causing serious and lasting harm to patients.